Inconsistent results between studies are also noted, especially regarding the possible effect of APOE4 toward amyloid-beta burden for both PD and DLB, reduced cortical thickness in PD patients, and alterations in brain volumes and WMH in DLB patients (See Figure 2). The gene discussed is APOE; the disease is Parkinson disease.